{"id":17422,"date":"2026-05-11T17:23:04","date_gmt":"2026-05-11T15:23:04","guid":{"rendered":"https:\/\/bbmri.at\/?post_type=news-articles&p=17422"},"modified":"2026-05-18T20:42:44","modified_gmt":"2026-05-18T18:42:44","slug":"vorarlberger-gesundheitsvorsorge-und-monitoring-programm","status":"publish","type":"news-articles","link":"https:\/\/bbmri.at\/de\/news-articles\/vorarlberger-gesundheitsvorsorge-und-monitoring-programm\/","title":{"rendered":"Vorarlberger Gesundheitsvorsorge- und Monitoring-Programm"},"content":{"rendered":"
\n
\n
\n \n

\n Vorarlberger Gesundheitsvorsorge- und Monitoring-Programm
\r\n(VHM&PP) <\/h1>\n \n

\n Eine ausgezeichnete Kohorte der pr\u00e4ventiven Gesundheitsversorgung der Agentur f\u00fcr Pr\u00e4ventiv- und Sozialmedizin (Arbeitskreis f\u00fcr Vorsorge- und Sozialmedizin, aks gesundheit GmbH) <\/h3>\n \n
\n

Das Vorarlberger Gesundheitssvorsorge- und Monitoring Programm (VHM&PP)<\/a> von aks Wissenschaft<\/a> ist eine der gr\u00f6\u00dften Gesundheitsdatenbanken der Welt.<\/p>\n

 <\/p>\n

Es enth\u00e4lt Datens\u00e4tze von Gesundheitsprogrammen in Vorarlberg. Die ersten Daten wurden Mitte der 1960er-Jahre im Rahmen pr\u00e4ventivmedizinischer Untersuchungen erhoben. Zwischen 1985 und 2005 wurden im Rahmen der prospektiv dokumentierten Vorarlberger Gesundheitschecks \u00fcber 700.000 Untersuchungen bei rund 180.000 Personen durchgef\u00fchrt.<\/p>\n

 <\/p>\n

Ziel der Kohorte ist es, Risikofaktoren f\u00fcr Erkrankungen \u2013 insbesondere kardiovaskul\u00e4re und maligne Erkrankungen \u2013 offenzulegen, um eine effiziente und zielgerichtete gesundheitsbezogene Planung und Entscheidungsfindung zu erm\u00f6glichen. Diese Datenkohorte bietet eine solide Grundlage, um Zusammenh\u00e4nge zwischen medizinischen Daten, Lebensstil, Umwelteinfl\u00fcssen und Gesundheitsrisiken zu erforschen.<\/p>\n <\/div>\n \n <\/div>\n\n\n\n

<\/div>\n <\/div>\n\n <\/div>\n\n\n
\r\n
\r\n
\r\n

\r\n Profil der Kohorte (in Englisch): <\/h3>\r\n \r\n \r\n\r\n
\r\n
\r\n

\r\n <\/h4>\r\n

\r\n <\/h4>\r\n <\/div>\r\n\r\n
\r\n
\r\n
\r\n Research Area <\/div>\r\n
\r\n Risk factors for diseases, in particular cardiovascular and malignant diseases <\/div>\r\n <\/div>\r\n
\r\n
\r\n Cohort Type <\/div>\r\n
\r\n Human population-based health data cohort, <\/div>\r\n <\/div>\r\n
\r\n
\r\n Cohort Size <\/div>\r\n
\r\n >180,000 participants (males, females domiciled in Vorarlberg) <\/div>\r\n <\/div>\r\n
\r\n
\r\n Donors\/ Participants <\/div>\r\n
\r\n Participants of the general health examination in Vorarlberg 1985-2005 aged \u226519 years, residence in Vorarlberg at time of examination <\/div>\r\n <\/div>\r\n
\r\n
\r\n Biological Sample Types
\r\n <\/div>\r\n
\r\n no biological samples collected in the cohort <\/div>\r\n <\/div>\r\n
\r\n
\r\n Associated Data <\/div>\r\n
\r\n \u2022\t(Socio-)demographics,
\r\n\u2022\tMedical history,
\r\n\u2022\tSymptoms,
\r\n\u2022\tPhysical examination,
\r\n\u2022\tClinical laboratory and imaging parameters,
\r\n\u2022\tCancer screening results (mammography, skin, colon),
\r\n\u2022\tLifestyle factors,
\r\n\u2022\tNutrition
\r\nFor details see figure below
\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n Collection Period <\/div>\r\n
\r\n 1985 \u2013 2005, routine annual follow-up for survival and cancer incidence ongoing <\/div>\r\n <\/div>\r\n
\r\n
\r\n Informed Consent <\/div>\r\n
\r\n \u2022\tWritten informed consent by all participants,
\r\n\u2022\tAdditional broad consent approved by the local ethics committee in 2006 and 2021, yearly updated
\r\n <\/div>\r\n <\/div>\r\n
\r\n
\r\n Access <\/div>\r\n
\r\n Yes – collaboration preferred <\/div>\r\n <\/div>\r\n
\r\n
\r\n Quality Standards <\/div>\r\n
\r\n Clinical laboratory and imaging parameters acquired as part of clinical routine <\/div>\r\n <\/div>\r\n
\r\n
\r\n Contact <\/div>\r\n
\r\n Principal investigators:
\r\n\u2022\tPrim. Priv.-Doz. Dr. Emanuel Zitt, Emanuel.Zitt@aks.or.at
\r\n\u2022\tDr. Mag. Dr. Wolfgang Brozek, Wolfgang.Brozek@aks.or.at
\r\nFurther contact:
\r\n\u2022\tProf. Mag. Dr. Hanno Ulmer, Hanno.Ulmer@aks.or.at <\/div>\r\n <\/div>\r\n
\r\n
\r\n Publications (scientific) <\/div>\r\n
\r\n More than 150 scientific publications in peer reviewed journals 2003 \u2013 2025
\r\nPublication list see below <\/div>\r\n <\/div>\r\n
\r\n
\r\n Research Projects <\/div>\r\n
\r\n \u201cLangzeit-Evaluation des Vorarlberger Melanom-Screening-Programms\u201d (F\u00f6rderung des Landes Vorarlberg 2022\/23)
\r\n\u2022\t„Gamma-Glutamyl-Transferase (GGT) als potenzieller Serum-Marker f\u00fcr das Risiko von H\u00fcftfrakturen“ (F\u00f6rderung des Landes Vorarlberg 2021\/22)
\r\n\u2022\t\u201cEvaluation des Vorarlberger Mammographie Screening-Projektes 1.1.1989 bis 31.12.2016 mit Berechnung von Inzidenz-, Mortalit\u00e4tsraten, Unter- und \u00dcberdiagnosen\u201d (F\u00f6rderung des Landes Vorarlberg 2018\/19)
\r\n\u2022\tSeveral grants of the WCRF (World Cancer Research Fund) (2008-2016)
\r\n\u2022\t7th Framework Programme of the European Community
\r\n\u2022\tGrant of the HEI (Health Effects Institute)
\r\n
\r\nMajor research projects in recent years with VHM&PP involvement include:
\r\n\u2022\tMe-Can Project: Metabolic Syndrome and Cancer Project
\r\n\u2022\tESCAPE: European Study of Cohorts for Air Pollution Effects
\r\n\u2022\tELAPSE: Effects of Low-Level Air Pollution: A Study in Europe
\r\n\u2022\tERFC: Emerging Risk Factors Collaboration
\r\n\u2022\tNCD-RisC: Non-Communicable Disease Risk Factor Collaboration <\/div>\r\n <\/div>\r\n <\/div>\r\n \r\n <\/div>\r\n <\/div>\r\n\r\n
<\/div>\r\n\r\n <\/div>\r\n <\/div>\r\n\n\n
\r\n
\r\n
\r\n
\r\n \r\n \"\"\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
<\/div>\r\n\r\n <\/div>\r\n <\/div>\r\n\n\n
\r\n
\r\n
\r\n
\r\n \r\n \"\"\r\n <\/span>\r\n <\/a>\r\n <\/div>\r\n <\/div>\r\n
<\/div>\r\n\r\n <\/div>\r\n <\/div>\r\n\n\n